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Abstract
Aim: To investigate maternal and perinatal outcomes (maternal death, preterm delivery, low birth weight and perinatal 
mortality) of dengue at PortSudan and Elmawani hospitals in the eastern Sudan.
Method: This was a retrospective Cohort study where medical files of women with dengue were reviewed.
Results: There were 10820 deliveries and 78 (0.7%) pregnant women with confirmed dengue IgM serology at the 
mean (SD) gestational age of 29.4(8.2) weeks. While the majority of these women had dengue fever (46, 58.9%), 
hemorrhagic fever and dengue shock syndrome were the presentations in 18 (23.0%) and 12, (15.3%) of these women, 
respectively. There were 17(21.7%) maternal deaths. Fourteen (17.9%) of these 78 women had preterm deliveries and 
19 (24.3%) neonates were admitted to neonatal intensive care unit. Nineteen (24.3%) women gave birth to low birth 
weight babies. There were seven (8.9%) perinatal deaths. Eight (10.2%) patients delivered by caesarean section due to 
various obstetrical indications.
Conclusion: Thus dengue has poor maternal and perinatal outcomes in this setting. Preventive measures against 
dengue should be employed in the region, and more research on dengue during pregnancy is needed.
Introduction
Dengue is the most common mosquito-borne infection,
with an estimated 100 million infections worldwide per
year [1-3]. Many factors like urbanization, increased pop-
ulation density, air travel, and limited resources for den-
gue prevention has led to dengue becoming a major
public health problem in the tropics [3]. Of the 100 mil-
lion annual infections, 250-500 thousand persons mani-
fest severe disease, with the remainder being mild,
nonspecific, or even asymptomatic [1-3].
Classic dengue fever (DF) is defined by the World
Health Organization as an acute febrile illness with two
more of the following signs or symptoms: intense head-
ache, retro-orbital pain, myalgia, arthralgia, rash, leu-
copenia, and a hemorrhagic manifestation [4]. A small
proportion of infected persons develop (dengue hemor-
rhagic fever (DHF), which is characterized by fever,
thrombocytopenia, hemorrhagic manifestations, and
increased vascular permeability with plasma leakage pri-
marily into the pleural cavity and peritoneum [5]. The
main clinical feature differentiating DF from DHF and
dengue shock syndrome (DSS) is the increased vascular
permeability, which, if unrecognized or not judiciously
treated may result in hypovolemic shock, organ impair-
ment, and death [6].
Dengue during pregnancy may be associated with vari-
ous complications, including maternal mortality, preterm
delivery, fetal death, low birth weight, neonatal admis-
sions, fetal anomalies, and miscarriage [7-14]. However,
the vast majority of these reports were case series and
from south East Asia. Thus, there is an urgent need to
investigate the presentation and outcomes of dengue so
as to provide caregivers and health planners with funda-
mental data necessary for the practicing clinicians as well
as researchers.
Dengue have been reported in different regions of the
Sudan - which the largest African country - including the
study area PortSudan [15,16]. Despite the prevalence of
dengue in Sudan, there are no data on the maternal and
fetal consequences of dengue during pregnancy. The
present study was conducted to investigate maternal and
perinatal outcomes of dengue infection at PortSudan and
Elmawani maternity hospitals in the eastern Sudan.
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Methods
All dengue cases presented at PortSudan and Elmawani
hospitals during 2008 - 2009 were reviewed retrospec-
tively. These two maternity hospitals provide tertiary care
for women who receive antenatal care at the hospital, as
well as for referrals from other clinics and hospitals, and
for women who live close to the hospital facility. All
women with risk factors or obstetric complications are
referred to this hospital. However, the referral criteria are
not strictly adhered to and many patients without any sig-
nificant complications presented at the hospital.
The medical files of all women with dengue were
reviewed; patients' records retrieved and the age, parity,
residence, gestational and maternal and perinatal out-
comes and biochemical characteristics were recorded.
Following our previous collaborations with Sudanese
national ministry of health in the different epidemics
[17,18] we have been consulted during this dengue epi-
demic and the diagnosis or exclusion of dengue was con-
ducted in the epidemiological lab in Khartoum under
supervision of one of our team (MSK).
A maternal death was defined as the death of a woman
while pregnant or within 42 days of termination of preg-
nancy, irrespective of the duration and site of the preg-
nancy, from any cause.
Miscarriage was defined as the expulsion of the fetus
before 28 weeks of gestation, and preterm delivery as a
delivery that occurred between 28 and 37 weeks of preg-
nancy. Low birth weight is the baby delivered weighting
<2500 gm. Perinatal mortality was defined as the number
of deaths of newborns born after ≥28 weeks of gestation
till the end of day 7.
Statistics
Data were entered into a computer database and SPSS
software (SPSS Inc., Chicago, IL, USA, version 13.0) and
double checked before analysis. Values are reported as
frequency, percentage, and mean (SD).
Results
During the period of study there were 10820 deliveries
and 78 (0.7%) pregnant women with confirmed dengue
serology IgM using ELISA at the mean (SD) gestational
age of 29.4(8.2) weeks. While the majority of these cases
were dengue fever (46, 58.9%), hemorrhagic fever and
dengue shock syndrome were the presentations in (18,
23.0%) and (12, 15.3%), respectively. The socio-demo-
graphic characteristics were shown in table 1. Various
symptoms were observed among these patients including
headache, fever, muscle pain or arthralgia, abdominal
pain, retro-orbital pain and rash. Five (6.4%) and three
(3.8%) patients had vaginal bleeding and epistaxis,
respectively.
There were 17(21.7%) maternal death due to multiple
organ failure and haemorrhage; all of these deaths were
dengue hemorrhagic fever and dengue shock syndrome.
Fourteen (17.9%) of these 78 women had preterm deliver-
ies and 19 (24.3%) neonates were admitted to neonatal
intensive care unit. Nineteen (24.3%) women gave birth
to low birth weight babies. There was no fetal anomaly.
There were seven (8.9%) perinatal deaths. Eight (10.2%)
patients delivered by caesarean delivery due to various
obstetrics indications, table 2.
Discussion
Perhaps this is largest study investigated maternal and
perinatal outcomes of dengue during pregnancy. The
main findings of this study were the poor maternal and
perinatal outcomes due to dengue mainly maternal
deaths (21.7%) and preterm deliveries (24.3%). We
recently reported a high maternal mortality in different
regions of Sudan due to various infectious diseases
[19,20] for example four (4.9%) out of 42 and 25% of the
sixteen women died due to visceral leishmaniasis and
viral hepatitis, respectively [17,21]. However, in Sudan, as
in many sub-Saharan countries, the frequency rates of
miscarriage, preterm labor, and congenital abnormalities
in the general population are unknown. In Malaysia, out
of 16 patients with dengue, there were three cases of
maternal death, 50.0% of the women had preterm deliver-
ies and three babies required intensive care [9]. Previ-
ously, it have been reported that maternal clinical dengue
Table 1: Baseline socio-demographic and biochemical 
characteristics of the 78 pregnant patients with dengue
Characters Mean (SD)
Age, years 28.9(6.8)
Parity 2.8(2.3)
Duration of illness 5.6 (2.3)
Weight, kg 62(6.8)
Gestational age 29.4(8.2)
Temperature 37.8 (0.8)
Haemoglobin, gm/dl 7.9(2.7)
Blood glucose, mg/dL 121.5 (8. 9)
Creatinine, mg/dL 1.4 (0.6)
Platelets, cells/μL 128, 568 (18.225)
White blood cells, cells/μL 3425 (4565.7)
Total protein, g/dL 7.8 (0.78)
Serum bilirubin, mg/dL 1.2 ± 0.9
Alanine aminotransferase, 
IU/L
65.9 ± 21.7
Aspartate aminotransferase, 
IU/L
82.6 ± 19.5Adam et al. Virology Journal 2010, 7:153
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may be associated with pregnancy complications, includ-
ing maternal mortality, preterm delivery, fetal death, low
birth weight, neonatal admissions, fetal anomalies, and
miscarriage [7-14]. These reports should be compared
with ours cautiously, because in this setting we might
have observed the severe form of the disease. In contrast
to other Asiatic countries, dengue is not endemic in
Sudan and epidemics occur from time to another, which
explains the lack of immunity in the population and the
severity of the disease. Hyperendemic conditions are
associated with an increased probability of secondary
infections and occurrence of virulent strains. Despite
these trends, little research has been conducted to exam-
ine the impact of the severity of maternal dengue infec-
tion. This is an important factor to assess because viral
titers are thought to vary by severity of infection, and
pathogenesis associated with poor pregnancy outcomes
can be caused by either the direct effect of the virus or the
body's response to high titers [22-24]. On the other hand
there were no any significant differences in pregnancy
outcome comparing dengue IgM-positive with IgM-neg-
ative women, perhaps in mild or asymptomatic dengue in
pregnant women [25]. However, our study was a hospital-
based one which might not reflect what was at the com-
munity level.
In the current study, 5 (6.4%) patients had vaginal
bleeding and 8 (10.2%) patients delivered by caesarean
delivery. The risk of maternal haemorrhage was reported
before when caesarean section was carried out on patient
with dengue fever [14]. Furthermore, difficulties in main-
taining haemostasis during the caesarean section were
observed too [14]. Deliveries were sometimes pathologi-
cal, so the risk of haemorrhage has to be assessed and
precautions should be taken both for natural delivery and
caesarean section. Generally in tropics the situations
sometimes are not clear and many infections/toxicity
may mimic the obstetrical emergency for example we
recently observed association between antepartum hae-
morrhage and snake bite [26].The impact of dengue on
pregnancy is not fully understood. Studies in the litera-
ture are limited and case studies were too small to draw
conclusions.
Conclusion
Thus dengue has poor maternal and perinatal outcomes
in this setting. Preventive measures against dengue
should be employed in the region, and more research on
dengue during pregnancy is needed.
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